Method of obtaining a composition comprising a 5-HT1D selective compound
AssigneeSynaptic Pharmaceutical Corporation
InventorsRichard L. Weinshank, Theresa Branchek, Paul R. Hartig
Life of this patent
Estimating the term…
Loading patent…
AssigneeSynaptic Pharmaceutical Corporation
InventorsRichard L. Weinshank, Theresa Branchek, Paul R. Hartig
Estimating the term…
This invention provides isolated nucleic acid molecules encoding human 5-HT1D receptors, isolated proteins which are human 5-HT1D receptors, vectors comprising isolated nucleic acid molecules encoding human 5-HT1D receptors, mammalian cells comprising such vectors, antibodies directed to human 5-HT1D receptors, nucleic acid probes useful for detecting nucleic acid encoding human 5-HT1D receptors, antisense oligonucleotides complementary to any sequences of a nucleic acid molecule which encodes a human 5-HT1D receptor, pharmaceutical compounds related to human 5-HT1D receptors, and nonhuman transgenic animals which express DNA which encodes a normal or a mutant human 5-HT1D receptor. This invention further provides methods for determining ligand binding, detecting expression, drug screening, and treatment involving the human 5-HT1D receptor.
A method of obtaining a composition which comprises determining whether a chemical compound binds to (a) a human 5-HT1D receptor expressed on the surface of a mammalian cell transfected with a vector adapted for expressing the receptor in the cell or (b) a human 5-HT1D receptor present in a membrane preparation obtained from such a mammalian cell, and if the chemical compound binds to the receptor in (a) or (b), recovering the chemical compound free of any 5-HT1D receptor and admixing the chemical compound with a carrier;
A method of obtaining a composition which comprises screening compounds to identify a compound which interacts with, and specifically binds to, (a) a human 5-HT1D receptor expressed on the surface of a mammalian cell transfected with a vector adapted for expressing the receptor in the cell or (b) a human 5-HT1D receptor present in a membrane preparation obtained from such a mammalian cell, and if the compound interacts with, and specifically binds to the receptor in (a) or (b), recovering the compound free of any 5-HT1D receptor and admixing the compound with a carrier;
Dependencies are inferred from the claim text.